MX9307203A - STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED. - Google Patents

STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED.

Info

Publication number
MX9307203A
MX9307203A MX9307203A MX9307203A MX9307203A MX 9307203 A MX9307203 A MX 9307203A MX 9307203 A MX9307203 A MX 9307203A MX 9307203 A MX9307203 A MX 9307203A MX 9307203 A MX9307203 A MX 9307203A
Authority
MX
Mexico
Prior art keywords
compounds
substituted
carboxi
dieno
acil
Prior art date
Application number
MX9307203A
Other languages
Spanish (es)
Inventor
Dennis Alan Holt
Mark Alan Levy
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929224213A external-priority patent/GB9224213D0/en
Priority claimed from GB939316954A external-priority patent/GB9316954D0/en
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MX9307203A publication Critical patent/MX9307203A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0014—Androstane derivatives substituted in position 17 alfa, not substituted in position 17 beta
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0066—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by a carbon atom forming part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Abstract

Se describen análogos de acil-3-carboxi-3,5-dieno 17Ó y 17ß substituídos de compuestos sintéticos esteroidales, composiciones farmacéuticas que contienen estos compuestos y métodos para usar estos compuestos para inhibir 5-Ó-reductasa esteroidal. También se describen compuestos intermediarios y procedimientos usados en la preparación de estos compuestos.Described 17O and 17ß substituted acyl-3-carboxy-3,5-diene analogues of steroidal synthetic compounds, pharmaceutical compositions containing these compounds, and methods of using these compounds to inhibit steroidal 5-O-reductase are described. Intermediate compounds and procedures used in the preparation of these compounds are also described.

MX9307203A 1992-11-18 1993-11-17 STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED. MX9307203A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929224213A GB9224213D0 (en) 1992-11-18 1992-11-18 Compounds
GB939316954A GB9316954D0 (en) 1993-08-14 1993-08-14 Compounds

Publications (1)

Publication Number Publication Date
MX9307203A true MX9307203A (en) 1994-07-29

Family

ID=26302003

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9307203A MX9307203A (en) 1992-11-18 1993-11-17 STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED.

Country Status (12)

Country Link
EP (2) EP0673251A1 (en)
JP (1) JPH08503471A (en)
CN (2) CN1101914A (en)
AP (1) AP9300589A0 (en)
AU (2) AU5613394A (en)
CA (1) CA2149427A1 (en)
IL (1) IL107611A0 (en)
MA (1) MA23036A1 (en)
MX (1) MX9307203A (en)
NZ (1) NZ258723A (en)
SI (1) SI9300601A (en)
WO (2) WO1994011386A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
GB9415178D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 4-azasteroids with side-chain fluoroketones
GB9415183D0 (en) * 1994-07-28 1994-09-21 Erba Carlo Spa 3-carboxysteroids with a fluorinated side-chain
EP0784627A4 (en) * 1994-10-05 1998-05-06 Smithkline Beecham Corp Process for preparing 17-beta-substituted-androsta-3,5-dien-3-carboxylic acids
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents
KR100540046B1 (en) 1997-11-12 2006-01-10 미쓰비시 가가꾸 가부시키가이샤 Purine Derivatives and Medicine Containing the Same as the Active Ingredient
KR100747106B1 (en) 1999-05-11 2007-08-08 미쯔비시 가가꾸 가부시끼가이샤 Purine Derivative Dihydrate, Drugs Containing the Same as the Active Ingredient and Intermediate in the Production Thereof
FR2817257B1 (en) 2000-11-30 2009-03-20 Sanofi Synthelabo CYCLOHEXYL (ALKYL) -PROPANOLAMINES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB201102913D0 (en) 2011-02-18 2011-04-06 Univ Birmingham Novel therapeutic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4910226A (en) * 1987-04-29 1990-03-20 Smithkline Beckman Corporation Steroid 5-alpha-reductase inhibitors
US5041433A (en) * 1987-04-29 1991-08-20 Smithkline Beecham Corporation 11-keto or hydroxy 3,5-diene steroids as inhibitors of steriod 5-α-reductase
US4954446A (en) * 1988-05-25 1990-09-04 Smithkline Beecham Corporation Aromatic steroid 5-α-reductase inhibitors
US5032586A (en) * 1989-08-24 1991-07-16 Smithkline Beecham Corporation 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase
US5137882A (en) * 1990-06-11 1992-08-11 Holt Dennis A Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors
US5091380A (en) * 1990-06-28 1992-02-25 Merck & Co., Inc. N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors
CA2045866A1 (en) * 1990-06-28 1991-12-29 Gary H. Rasmusson 17-beta-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5 alpha-reductase inhibitors
EP0465123A3 (en) * 1990-06-28 1992-05-06 Merck & Co. Inc. New intermediates in the synthesis of 17beta-acyl-3-carboxy-androsta-3,5-dienes
US5196411A (en) * 1991-08-16 1993-03-23 Merck & Co., Inc. 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors

Also Published As

Publication number Publication date
AU5671794A (en) 1994-06-08
WO1994011004A1 (en) 1994-05-26
AU5613394A (en) 1994-06-08
AP9300589A0 (en) 1994-01-31
SI9300601A (en) 1994-06-30
CN1101914A (en) 1995-04-26
EP0669932A1 (en) 1995-09-06
CA2149427A1 (en) 1994-05-26
WO1994011386A1 (en) 1994-05-26
EP0673251A1 (en) 1995-09-27
EP0669932A4 (en) 1995-10-25
EP0673251A4 (en) 1995-10-25
NZ258723A (en) 1996-12-20
MA23036A1 (en) 1994-07-01
JPH08503471A (en) 1996-04-16
IL107611A0 (en) 1994-02-27
CN1101916A (en) 1995-04-26

Similar Documents

Publication Publication Date Title
MY103518A (en) Steroid 5- -reductase inhibitors
MX9204268A (en) A COMPOSITION FOR THE PROLONGED AND CONTROLLED RELEASE OF MEDICINAL SUBSTANCES AND A PROCESS TO PREPARE THE SAME.
ATE26115T1 (en) SUBSTITUTED 8-PHENYLXANTHINS.
MX9204354A (en) HETERO-CYCLE COMPOUNDS OF 5 MEMBERS, PROCEDURE TO PREPARE THEM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
ES2155874T3 (en) COSMETIC COMPOSITIONS CONTAINING BETULIN ACID.
ES2142034T3 (en) BIAROMATIC COMPOUNDS CARRYING A GROUP ADAMANTILO IN ORTO, PHARMACEUTICAL AND COSMETIC COMPOSITIONS THAT CONTAIN THEM AND UTILIZATIONS.
BR9714082A (en) Compound, use thereof, pharmaceutical composition, and, processes for treatment or prophylaxis of inflammatory diseases, and for the preparation of a compound.
ES2090713T3 (en) ORGANIC SALTS OF N, N'-DIACETIL-CYSTINE.
UA66750C2 (en) Substituted 1-phenylpirazole 3-carboxamides, a method for the preparation thereof and intermediary compounds, pharmaceutical composition having affinity to neurotensin receptors
ES2018478B3 (en) A SYSTEM TO PREPARE A DENTAL DESENSITIZING COMPOSITION.
FI953442A (en) Freeze-dried spheres containing gonadotropin
CO4290432A1 (en) NEW DERIVATIVES OF PIRAZINACARBOXAMIDA, ITS PREPARATION AND ITS USE IN MEDICINES.
PT83933B (en) PROCESS FOR THE PREPARATION OF STABLE COMPOSITIONS OF HUMAN PLASMINOGEN ACTIVATOR, TISSUE TYPE
MX9300407A (en) AZABICICLIC DERIVATIVES USED IN THE MANUFACTURE OF MEDICINES, CONTAINING COMPOSITIONS AND PROCEDURE FOR THE PREPARATION.
BG99177A (en) New 7 -substituted-4-aza-5 - cholestanones as inhibitors of 5 - reductase
ES2104090T3 (en) NEW 3 ', 5'-DI-T-BUTIL-4'-HIDROXI-FLAVONAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
IE873125L (en) Benzimidazole derivatives
MX9307203A (en) STEROIDAL COMPOUNDS OF ACIL-3-CARBOXI-3,5-DIENO-17Ó AND 17ß-SUBSTITUTED.
AR015945A1 (en) AUTOFOBIC HAIR SPRAY COMPOSITIONS
ES2174054T3 (en) PHARMACEUTICAL LIQUID PHARMACEUTICAL COMPOSITIONS INCLUDING SODIUM ALGINATE AND POTASSIC BICARBONATE.
AR012546A1 (en) USE OF AT LEAST ONE SELECTED COMPOUND BETWEEN THE GROUP COMPRISING THE SOGAOLS AND THE GINGEROLES FOR THE PREPARATION OF A COMPOSITION DEODORANTE, SOGAOL, GROSS EXTRACT AND PURIFIED EXTRACT CONTAINING THE SOGAOL AND THE DEODANT COMPOSITION.
ECSP941120A (en) DERIVATIVES OF 1,5 BENZODIAZEPINA
ES2130598T3 (en) COSMETIC AND / OR PHARMACEUTICAL PREPARATIONS.
BR9806193A (en) Bi-aromatic composition linked by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing them
MX9300406A (en) AZABICICLIC DERIVATIVES PROCEDURES FOR ITS PREPARATION AND COMPOSITIONS THAT CONTAIN THEM.